Before becoming LegalReader's Editor-in-Chief, Jay W. Belle Isle worked as a freelance copywriter with clients on four continents. Jay has a degree in Business Administration from Cleary University and a Juris Doctor from Thomas M. Cooley Law School. Jay has also worked as a contracts administrator for a DOD contractor specializing in vehicle armor.
Last week, Big Pharma giants Bayer and Johnson & Johnson scored a victory in the second bellwether trial involving the popular blood thinning drug, Xarelto. A federal jury in New Orleans handed down the verdict clearing the companies of all liability for Sharyn Orr’s 2015 death.
WannaCry affected those in 153 different countries, it was so widespread. Even law firms aren’t safe from cybercriminals. But VIPole has a plan to keep lawyers safe from security breaches.
This post is a reprint of an email update the Essure Problems Facebook admin team sent to the FDA. Reprinted with permission.
Last week, a jury in federal court in East St. Louis, Illinois sided with a ten-year old boy who was born with spina bifida. The boy’s lawsuit, filed by his mother, alleged that AbbVie’s popular bipolar medication, Depakote, was the cause of his birth defect.
It’s been a great week for women’s health in Europe. Just the other day, I had the pleasure of writing a piece on Bayer pulling Essure from the market in Finland. Today, thanks to a number of readers, I get the joy of writing a similar piece. It has been confirmed by Bayer that the company is withdrawing from the UK market as of September 1, 2017.
It’s your worst nightmare. After years of carefully managing your finances, some unscrupulous individual steals your identity and begins opening accounts, taking loans, and committing you to deal with the aftermath. All your hard work, gone in the time it took a thief to fill out some applications (most of which are now done online).
I was recently contacted by a fellow writer in reference to the letter you’re about to read. Due to my coverage of the Essure issue, he thought that our readers would like to see Dr. Novoa’s Essure letter to fellow doctors. It’s with my colleague’s permission that I share their post and Dr. Novoa’s letter.
It’s with great sadness that I write this piece. On May 24, 2017, the world lost an amazing advocate for women’s health. Dr. Amy Reed died at her home in Yardley, Pennsylvania at age 44, after a long battle with leiomyosarcoma of the uterus.
I’m not going to take a picture of myself attempting to jump up and down; no one but my chiropractor wants to see that! However, the sentiment is very much present as I get to write these incredible words: Essure is soon to be history in Finland!
Last week, the first bellwether trial over Xarelto, a “new generation” blood thinner jointly developed by Bayer and Johnson & Johnson, concluded. The jury found in favor of the Big Pharma defendants on Wednesday, after less than three hours of deliberation. Bellwether trials are a means for parties and attorneys to test their arguments and